Schott Poonawalla says it is now Schott Pharma
In short
Schott Poonawalla now says it is Schott Pharma. CEO and Managing Director Roy Joseph said the company is focused on helping deliver critical therapies safely and reliably worldwide.
This matters because the company is strengthening its place in the specialty glass market for medicine. The report does not give the date of the change or any financial figures.
What the reporting says
Schott Poonawalla, now Schott Pharma, said it remained focused on growing and contributing to the safe and reliable delivery of critical therapies worldwide, according to CEO and Managing Director Roy Joseph. The available reporting does not provide the timing of the name change, financial details, or any operational changes beyond the statement. The immediate takeaway is a brand and positioning update in specialty glass for pharma use.
Why it matters
Schott Poonawalla has become Schott Pharma, and CEO and Managing Director Roy Joseph said the company remains focused on growing and supporting the safe and reliable delivery of critical therapies worldwide. The reporting links the change to the specialty glass market used in pharma packaging. It does not provide a date, transaction details, or any financial impact from the rebranding.